A phase I/IIa safety, immunogenicity, and efficacy bridging randomized study of a two-dose regimen of liquid and lyophilized formulations of the candidate malaria vaccine RTS,S/AS02A in malaria-naïve adults. (Q47835936)
Jump to navigation
Jump to search
scientific article published on 30 May 2007
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A phase I/IIa safety, immunogenicity, and efficacy bridging randomized study of a two-dose regimen of liquid and lyophilized formulations of the candidate malaria vaccine RTS,S/AS02A in malaria-naïve adults. |
scientific article published on 30 May 2007 |
Statements
1 reference
A phase I/IIa safety, immunogenicity, and efficacy bridging randomized study of a two-dose regimen of liquid and lyophilized formulations of the candidate malaria vaccine RTS,S/AS02A in malaria-naïve adults. (English)
1 reference
Janet Wittes
1 reference
W Ripley Ballou
1 reference
Marie-Claude Dubois
1 reference
Christian F Ockenhouse
1 reference
D Gray Heppner
1 reference
Kent E Kester
1 reference
Denise A McKinney
1 reference
Nadia Tornieporth
1 reference
Ted Hall
1 reference
Bruce T Wellde
1 reference
Kate White
1 reference
Peifang Sun
1 reference
Robert Schwenk
1 reference
Urszula Krzych
1 reference
Martine Delchambre
1 reference
Gerald Voss
1 reference
Robert A Gasser
1 reference
Megan G Dowler
1 reference
Megan O'Brien
1 reference
Robert Wirtz
1 reference
Joe Cohen
1 reference
RTS,S Malaria Vaccine Evaluation Group
1 reference
30 May 2007
1 reference
1 reference
25
1 reference
29
1 reference
5359-5366
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference